(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are PAVmed, Ribbon Communications , and Organovo Holdings.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | PAVmed (PAVMW) | 0.03 | 105.67% | 2023-02-16 23:09:29 |
| 2 | Ribbon Communications (RBBN) | 4.63 | 21.84% | 2023-02-17 09:11:11 |
| 3 | Organovo Holdings (ONVO) | 3.20 | 21.21% | 2023-02-16 19:12:09 |
| 4 | DraftKings (DKNG) | 20.43 | 14.72% | 2023-02-17 15:47:43 |
| 5 | HubSpot (HUBS) | 404.54 | 11.77% | 2023-02-17 15:59:51 |
| 6 | Orchard Therapeutics plc (ORTX) | 0.60 | 11.73% | 2023-02-16 20:23:17 |
| 7 | Sorrento Therapeutics (SRNE) | 0.29 | 11.71% | 2023-02-17 15:15:16 |
| 8 | Full House Resorts (FLL) | 10.05 | 7.83% | 2023-02-17 15:56:48 |
| 9 | OpGen (OPGN) | 1.16 | 7.41% | 2023-02-16 19:14:08 |
| 10 | Xenetic Biosciences (XBIO) | 0.58 | 7.28% | 2023-02-17 14:51:46 |
The three biggest losers today are XP, Ontrak, and Dropbox.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | XP (XP) | 12.91 | -18.75% | 2023-02-17 15:50:33 |
| 2 | Ontrak (OTRKP) | 1.20 | -14.29% | 2023-02-16 21:13:10 |
| 3 | Dropbox (DBX) | 21.30 | -11.12% | 2023-02-17 15:53:13 |
| 4 | Albemarle (ALB) | 256.08 | -10.34% | 2023-02-17 15:51:15 |
| 5 | Precigen (PGEN) | 1.38 | -8.61% | 2023-02-17 01:11:09 |
| 6 | Antero Resources (AR) | 25.30 | -8.15% | 2023-02-17 15:54:48 |
| 7 | Sabre Corporation (SABR) | 5.34 | -7.54% | 2023-02-17 15:45:08 |
| 8 | SmileDirectClub (SDC) | 0.59 | -7.19% | 2023-02-17 14:50:39 |
| 9 | Pyxis Tankers (PXS) | 5.42 | -6.07% | 2023-02-17 07:46:19 |
| 10 | United States Steel (X) | 28.05 | -5.86% | 2023-02-17 15:52:12 |
Winners today
1. PAVmed (PAVMW) – 105.67%
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
NASDAQ ended the session with PAVmed rising 105.67% to $0.03 on Friday while NASDAQ slid 0.58% to $11,787.27.
Yearly Top and Bottom Value
PAVmed’s stock is valued at $0.03 at 16:32 EST, way under its 52-week high of $4.74 and way higher than its 52-week low of $0.02.
Volume
Today’s last reported volume for PAVmed is 32626 which is 397.12% above its average volume of 6563.
Moving Average
PAVmed’s value is way under its 50-day moving average of $0.21 and way under its 200-day moving average of $1.66.
More news about PAVmed.
2. Ribbon Communications (RBBN) – 21.84%
Ribbon Communications Inc. provides communications technology in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates through two segments, Cloud and Edge, and IP Optical Networks. The Cloud and Edge segment provides software and hardware products; and solutions and services for enabling voice over internet protocol communications, voice over long-term evolution, and voice over 5G communications and unified communications and collaboration. It also offers session border controller and network transformation products. This segment serves private, public, or hybrid cloud infrastructures, as well as data centers, enterprise premises, and service provider networks. It also provides multiple solutions for VoIP, VoLTE, VoNR, and UC&C in network, on-premises, or via the telco cloud. The IP Optical Networks segment provides hardware and software solutions for IP networking, switching, routing, and optical transport to support and enable technologies, such as 5G, distributed cloud computing, and corresponding applications. It also offers multiple solutions, including 5G-native solutions for mobile-backhaul, metro and edge aggregation, core networking, data center interconnect, legacy NTR, and transport solutions for wholesale carriers. This segment serves utilities, government, defense, finance, transportation, and education and research industries, as well as service providers and enterprises. It also provides advanced analytics solutions and next generation products that provides cloud-native and streaming analytics platform for networks and subscribers. The company was formerly known as Sonus Networks, Inc. and changed its name to Ribbon Communications Inc. in November 2017. Ribbon Communications Inc. was founded in 1997 and is headquartered in Plano, Texas.
NASDAQ ended the session with Ribbon Communications jumping 21.84% to $4.63 on Friday, after two consecutive sessions in a row of gains. NASDAQ dropped 0.58% to $11,787.27, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Ribbon Communications has a trailing twelve months EPS of $-1.365.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.97%.
Yearly Top and Bottom Value
Ribbon Communications ‘s stock is valued at $4.63 at 16:32 EST, under its 52-week high of $4.84 and way above its 52-week low of $2.19.
Moving Average
Ribbon Communications ‘s value is way higher than its 50-day moving average of $3.12 and way above its 200-day moving average of $2.98.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.3%, now sitting on 816.7M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 75% and a drop 16.7% for the next.
More news about Ribbon Communications .
3. Organovo Holdings (ONVO) – 21.21%
Organovo Holdings, Inc., a biotechnology company, develops bioprinted human tissues based on its 3D human tissue platform technology that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases; and NovoTissues liver product using cells from a liver donor and cells from an umbilical cord donor. The company was founded in 2007 and is headquartered in Solana Beach, California.
NASDAQ ended the session with Organovo Holdings rising 21.21% to $3.20 on Friday while NASDAQ fell 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Organovo Holdings has a trailing twelve months EPS of $-1.315.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -43.71%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Organovo Holdings’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Organovo Holdings is 882605 which is 988.97% above its average volume of 81049.
More news about Organovo Holdings.
4. DraftKings (DKNG) – 14.72%
DraftKings Inc. operates a digital sports entertainment and gaming company. It offers multi-channel sports betting and gaming technologies, powering sports and gaming entertainment for operators in 17 countries. The company operates iGaming through its DraftKings brand in 5 states, as well as operates Golden Nugget Online Gaming, an iGaming product and gaming brand in 3 states. Its Sportsbook is live with mobile and/or retail betting operations in the United States pursuant to regulations in 18 states. The company's daily fantasy sports product is available in 6 countries internationally with 15 distinct sports categories. In addition, it offers DraftKings Marketplace, a digital collectibles ecosystem designed for mainstream accessibility that offers curated NFT drops and supports secondary-market transactions, as well as owns Vegas Sports Information Network (VSiN), a multi-platform broadcast and content company. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
NASDAQ ended the session with DraftKings jumping 14.72% to $20.43 on Friday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, DraftKings has a trailing twelve months EPS of $-3.62.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -78.41%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DraftKings’s stock is considered to be oversold (<=20).
Moving Average
DraftKings’s value is way higher than its 50-day moving average of $13.84 and way higher than its 200-day moving average of $14.45.
Volatility
DraftKings’s last week, last month’s, and last quarter’s current intraday variation average was 2.78%, 1.00%, and 3.01%.
DraftKings’s highest amplitude of average volatility was 2.78% (last week), 3.17% (last month), and 3.01% (last quarter).
Yearly Top and Bottom Value
DraftKings’s stock is valued at $20.43 at 16:32 EST, way below its 52-week high of $25.01 and way above its 52-week low of $9.77.
More news about DraftKings.
5. HubSpot (HUBS) – 11.77%
HubSpot, Inc. provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific. The company's CRM platform includes marketing, sales, service, and content management systems, as well as integrated applications, such as search engine optimization, blogging, website content management, messaging, chatbots, social media, marketing automation, email, predictive lead scoring, sales productivity, knowledge base, commerce, conversation routing, video hosting, ticketing and helpdesk tools, customer NPS surveys, analytics, and reporting. It also offers professional services to educate and train customers on how to leverage its CRM platform, as well as phone and/or email and chat-based support services. The company serves mid-market business-to-business companies. HubSpot, Inc. was incorporated in 2005 and is headquartered in Cambridge, Massachusetts.
NYSE ended the session with HubSpot rising 11.77% to $404.54 on Friday while NYSE fell 0.21% to $15,840.85.
Earnings Per Share
As for profitability, HubSpot has a trailing twelve months EPS of $-1.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.05%.
Volume
Today’s last reported volume for HubSpot is 2474890 which is 251.8% above its average volume of 703488.
Previous days news about HubSpot
- : hubspot stock rallies 13% after company’s Q4 sails above forecast. According to MarketWatch on Thursday, 16 February, "HubSpot Inc. stock rallied more than 13% in the extended session Thursday after the software company reported an adjusted per-share profit and sales above Wall Street expectations for its fourth quarter, saying it "stepped up to the challenging macroeconomic conditions that emerged in 2022." HubSpot lost $15.6 million, or 32 cents a share, in the quarter, compared with a loss of $16.4 million, or 35 cents a share, in the year-ago quarter. ", "Analysts polled by FactSet expected HubSpot to report adjusted earnings of 83 cents a share on sales of $446 million. "
More news about HubSpot.
6. Orchard Therapeutics plc (ORTX) – 11.73%
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom.
NASDAQ ended the session with Orchard Therapeutics plc jumping 11.73% to $0.60 on Friday, after three successive sessions in a row of gains. NASDAQ fell 0.58% to $11,787.27, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Orchard Therapeutics plc has a trailing twelve months EPS of $-1.528.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -98.15%.
More news about Orchard Therapeutics plc.
7. Sorrento Therapeutics (SRNE) – 11.71%
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.
NASDAQ ended the session with Sorrento Therapeutics rising 11.71% to $0.29 on Friday, following the last session’s upward trend. NASDAQ fell 0.58% to $11,787.27, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -326.72%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 56.1% and 35%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sorrento Therapeutics’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth declined by 15.2%, now sitting on 54.98M for the twelve trailing months.
More news about Sorrento Therapeutics.
8. Full House Resorts (FLL) – 7.83%
Full House Resorts, Inc. owns, develops, invests in, operates, manages, and leases casinos, and related hospitality and entertainment facilities in the United States. The company owns and operates the Silver Slipper Casino and Hotel in Hancock County, Mississippi, which has 757 slot machines and 24 table games, a surface parking lot, and a 129 hotel rooms; an on-site sportsbook, a fine-dining restaurant, a buffet, and a quick-service restaurant, as well as an oyster bar, a casino bar, and a beachfront bar; and 37-space beachfront RV park. It also owns and operates the Bronco Billy's Casino and Hotel in Cripple Creek, Colorado that has gaming space and 14 hotel rooms, as well as a steakhouse and a casual dining outlet. In addition, the company owns and operates the Rising Star Casino Resort in Rising Sun, Indiana, which has 642 slot machines and 16 table games; a land-based pavilion with approximately 31,500 square feet of meeting and convention space; a contiguous 190-guest-room hotel and an adjacent leased 104-guest-room hotel; a 56-space RV park; surface parking; an 18-hole golf course on approximately 230 acres; and four dining outlets. Further, it owns and operates the Stockman's Casino that is located in Fallon, Nevada, which has 186 slot machines, a bar, a fine-dining restaurant, and a coffee shop; and the Grand Lodge Casino that has 269 slot machines and 9 table games, which is integrated into the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada. Full House Resorts, Inc. was incorporated in 1987 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Full House Resorts rising 7.83% to $10.05 on Friday, following the last session’s upward trend. NASDAQ fell 0.58% to $11,787.27, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
PE Ratio
Full House Resorts has a trailing twelve months price to earnings ratio of 2010. Meaning, the purchaser of the share is investing $2010 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.12%.
Sales Growth
Full House Resorts’s sales growth is 3.6% for the present quarter and 11.3% for the next.
Yearly Top and Bottom Value
Full House Resorts’s stock is valued at $10.05 at 16:32 EST, under its 52-week high of $10.74 and way above its 52-week low of $4.82.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 115.4% and a negative 121.4%, respectively.
More news about Full House Resorts.
9. OpGen (OPGN) – 7.41%
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
NASDAQ ended the session with OpGen rising 7.41% to $1.16 on Friday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, OpGen has a trailing twelve months EPS of $-0.829.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -142.09%.
Yearly Top and Bottom Value
OpGen’s stock is valued at $1.16 at 16:32 EST, way under its 52-week high of $19.00 and way higher than its 52-week low of $0.98.
Revenue Growth
Year-on-year quarterly revenue growth declined by 63.8%, now sitting on 3.31M for the twelve trailing months.
Sales Growth
OpGen’s sales growth is negative 57.9% for the present quarter and 240.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
OpGen’s EBITDA is -1.16.
More news about OpGen.
10. Xenetic Biosciences (XBIO) – 7.28%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences rising 7.28% to $0.58 on Friday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 44.9%, now sitting on 1.49M for the twelve trailing months.
Volume
Today’s last reported volume for Xenetic Biosciences is 15345 which is 79.4% below its average volume of 74509.
Volatility
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.49%, a positive 2.28%, and a positive 5.37%.
Xenetic Biosciences’s highest amplitude of average volatility was 3.46% (last week), 5.95% (last month), and 5.37% (last quarter).
More news about Xenetic Biosciences.
Losers Today
1. XP (XP) – -18.75%
XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers Xpeed, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, private equity, structured products, credit cards, loan operations, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
NASDAQ ended the session with XP falling 18.75% to $12.91 on Friday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $0.99.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 13.09. Meaning, the purchaser of the share is investing $13.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.58%.
Volatility
XP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.77%, a negative 0.19%, and a positive 2.83%.
XP’s highest amplitude of average volatility was 2.37% (last week), 1.88% (last month), and 2.83% (last quarter).
More news about XP.
2. Ontrak (OTRKP) – -14.29%
Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. The company's technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.
NASDAQ ended the session with Ontrak sliding 14.29% to $1.20 on Friday while NASDAQ slid 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Ontrak has a trailing twelve months EPS of $-2.843.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -190.88%.
Yearly Top and Bottom Value
Ontrak’s stock is valued at $1.20 at 16:32 EST, way under its 52-week high of $10.88 and way higher than its 52-week low of $0.36.
Moving Average
Ontrak’s worth is way higher than its 50-day moving average of $1.05 and way under its 200-day moving average of $1.99.
Volume
Today’s last reported volume for Ontrak is 3576 which is 86.72% below its average volume of 26943.
Revenue Growth
Year-on-year quarterly revenue growth declined by 84.7%, now sitting on 22.34M for the twelve trailing months.
More news about Ontrak.
3. Dropbox (DBX) – -11.12%
Dropbox, Inc. provides a content collaboration platform worldwide. Its platform allows individuals, families, teams, and organizations to collaborate and sign up for free through its website or app, as well as upgrade to a paid subscription plan for premium features. As of December 31, 2021, the company had approximately 700 million registered users. It serves customers in professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
NASDAQ ended the session with Dropbox falling 11.12% to $21.30 on Friday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Dropbox has a trailing twelve months EPS of $-0.62.
Yearly Top and Bottom Value
Dropbox’s stock is valued at $21.30 at 16:32 EST, way below its 52-week high of $25.00 and way higher than its 52-week low of $19.07.
Volume
Today’s last reported volume for Dropbox is 10114500 which is 330.05% above its average volume of 2351910.
Sales Growth
Dropbox’s sales growth is 5% for the ongoing quarter and 4.9% for the next.
More news about Dropbox.
4. Albemarle (ALB) – -10.34%
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
NYSE ended the session with Albemarle sliding 10.34% to $256.08 on Friday, after five sequential sessions in a row of gains. NYSE dropped 0.21% to $15,840.85, after three successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Albemarle has a trailing twelve months EPS of $3.52.
PE Ratio
Albemarle has a trailing twelve months price to earnings ratio of 72.75. Meaning, the purchaser of the share is investing $72.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.66%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 565.7% and 729.7%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 91.2%, now sitting on 4.33B for the twelve trailing months.
Volatility
Albemarle’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.24%, a positive 0.35%, and a positive 2.16%.
Albemarle’s highest amplitude of average volatility was 1.66% (last week), 2.03% (last month), and 2.16% (last quarter).
Yearly Top and Bottom Value
Albemarle’s stock is valued at $256.08 at 16:32 EST, way below its 52-week high of $334.55 and way above its 52-week low of $169.93.
More news about Albemarle.
5. Precigen (PGEN) – -8.61%
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading S.A.; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Fibrocell Science, Inc.; OvaXon, LLC; S & I Ophthalmic, LLC; Harvest start-up entities; and Surterra Holdings, Inc. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
NASDAQ ended the session with Precigen falling 8.61% to $1.38 on Friday while NASDAQ fell 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Precigen has a trailing twelve months EPS of $-0.472.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.32%.
Yearly Top and Bottom Value
Precigen’s stock is valued at $1.38 at 16:32 EST, way below its 52-week high of $2.90 and way higher than its 52-week low of $1.12.
Moving Average
Precigen’s value is way under its 50-day moving average of $1.67 and way below its 200-day moving average of $1.76.
Revenue Growth
Year-on-year quarterly revenue growth grew by 401.7%, now sitting on 118.44M for the twelve trailing months.
More news about Precigen.
6. Antero Resources (AR) – -8.15%
Antero Resources Corporation, an independent oil and natural gas company, acquires, explores for, develops, and produces natural gas, natural gas liquids, and oil properties in the United States. As of December 31, 2021, it had approximately 502,000 net acres in the Appalachian Basin; and 174,000 net acres in the Upper Devonian Shale. The company also owned and operated 494 miles of gas gathering pipelines in the Appalachian Basin; and 21 compressor stations. It had estimated proved reserves of 17.7 trillion cubic feet of natural gas equivalent, including 10.2 trillion cubic feet of natural gas; 718 million barrels of assumed recovered ethane; 501 million barrels of primarily propane, isobutane, normal butane, and natural gasoline; and 36 million barrels of oil. The company was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. Antero Resources Corporation was founded in 2002 and is headquartered in Denver, Colorado.
NYSE ended the session with Antero Resources sliding 8.15% to $25.30 on Friday while NYSE fell 0.21% to $15,840.85.
Earnings Per Share
As for profitability, Antero Resources has a trailing twelve months EPS of $-3.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.74%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Antero Resources’s stock is considered to be overbought (>=80).
More news about Antero Resources.
7. Sabre Corporation (SABR) – -7.54%
Sabre Corporation, through its subsidiary, Sabre Holdings Corporation, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates as a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.
NASDAQ ended the session with Sabre Corporation dropping 7.54% to $5.34 on Friday, following the last session’s upward trend. NASDAQ slid 0.58% to $11,787.27, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-4.42.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sabre Corporation’s stock is considered to be overbought (>=80).
More news about Sabre Corporation.
8. SmileDirectClub (SDC) – -7.19%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub falling 7.19% to $0.59 on Friday, after two sequential sessions in a row of losses. NASDAQ dropped 0.58% to $11,787.27, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
Sales Growth
SmileDirectClub’s sales growth is negative 28.2% for the current quarter and negative 22.1% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 8.7% and 12%, respectively.
More news about SmileDirectClub.
9. Pyxis Tankers (PXS) – -6.07%
Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker sector in the United States. Its fleet transports refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, and fuel oil, as well as other liquid bulk items, including vegetable oils and organic chemicals. As of March 31, 2022, the company operated a fleet of five tankers. Pyxis Tankers Inc. was incorporated in 2015 and is based in Maroussi, Greece.
NASDAQ ended the session with Pyxis Tankers sliding 6.07% to $5.42 on Friday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Pyxis Tankers has a trailing twelve months EPS of $-0.32.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.37%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 142.5%, now sitting on 48.07M for the twelve trailing months.
Moving Average
Pyxis Tankers’s value is higher than its 50-day moving average of $5.19 and way above its 200-day moving average of $3.95.
Yearly Top and Bottom Value
Pyxis Tankers’s stock is valued at $5.42 at 16:32 EST, under its 52-week high of $5.99 and way above its 52-week low of $1.88.
More news about Pyxis Tankers.
10. United States Steel (X) – -5.86%
United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe. It operates through four segments: North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment offers slabs, strip mill plates, sheets, and tin mill products, as well as iron ore and coke. This segment serves customers in the service center, conversion, transportation, automotive, construction, container, appliance, and electrical markets. The Mini Mill segment provides hot-rolled, cold-rolled, and coated sheets and electrical products. This segment serves customers in the automotive, appliance, construction, container, transportation, and service center markets. The USSE segment provides slabs, strip mill plates, sheets, tin mill products, and spiral welded pipes. This segment serves customers in the construction, container, appliance and electrical, service center, conversion, oil, gas, and petrochemical markets. The Tubular segment offers seamless and electric resistance welded steel casing and tubing products, as well as standard and line pipe and mechanical tubing products primarily to customers in the oil, gas, and petrochemical markets. The company also engages in the real estate business. United States Steel Corporation was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
NYSE ended the session with United States Steel sliding 5.86% to $28.05 on Friday while NYSE dropped 0.21% to $15,840.85.
Earnings Per Share
As for profitability, United States Steel has a trailing twelve months EPS of $-3.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.75%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.2%, now sitting on 23.11B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, United States Steel’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for United States Steel is 7137140 which is 5.59% above its average volume of 6758960.
More news about United States Steel.
Stay up to date with our winners and losers daily report
